Related Experiment Video
Updated: Feb 8, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetic variation at the long noncoding RNA H19 gene is associated with the risk of hypertrophic cardiomyopathy
Juan Gómez1, Rebeca Lorca1, Julián R Reguero1
1Unidad de Referencia de Cardiopatías Familiares-HUCA, Genética Molecular y Cardiología, Hospital Universitario Central Asturias, Oviedo, Spain.
Insights
Genetic variants in the H19 gene are linked to an increased risk of developing hypertrophic cardiomyopathy (HCM). This finding offers new insights into the genetic factors contributing to HCM development.
Area of Science:
- Genetics
- Molecular Biology
- Cardiology
Background:
- The long noncoding RNA H19 and its host microRNA miR-675 are deregulated in cardiac hypertrophy and heart failure.
- Investigating genetic predispositions for cardiovascular diseases is crucial.
Purpose of the Study:
- To determine if H19 gene variants are associated with the risk of hypertrophic cardiomyopathy (HCM).
Main Methods:
- Genotyping of two H19 tag single nucleotide polymorphisms (SNPs) in 405 HCM patients and 550 controls.
- Sequencing of the H19 gene in 100 HCM patients.
Main Results:
- The rs2107425 C allele was significantly more frequent in HCM patients without sarcomere mutations (p=0.01).
- A rare H19 variant (rs945977096 G/A) was identified in two HCM patients but not in controls.
Conclusions:
- H19 gene variants show a significant association with the risk of developing HCM.
- These findings suggest H19 may play a role in HCM pathogenesis.
Aim:
The long noncoding RNA H19 and its host micro RNA miR-675 have been found deregulated in cardiac hypertrophy and heart failure tissues. Our aim was to investigate whether the H19 gene variants were associated with the risk of hypertrophic cardiomyopathy (HCM).
Patients & Methods:
We genotyped two H19 tag single nucleotide polymorphisms in 405 HCM patients and 550 controls, and sequenced this gene in 100 patients.
Results:
The rs2107425 C was significantly increased in sarcomere no-mutation patients (n = 225; p = 0.01): CC versus CT + TT, p = 0.017; odd ratios: 1.51. Sequencing of the H19 coding transcript identified two patients heterozygous carriers for a rare variant, rs945977096 G/A, that was absent among the controls.
Conclusion:
Our study suggested a significant association between H19 variants and the risk of developing HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Genetic Variation
Genes exist in different versions called alleles,...
Mutation, Gene Flow, and Genetic Drift
Cardiomyopathy II: Dilated Cardiomyopathy
What is Population Genetics?
Cardiomyopathy IV: Restrictive Cardiomyopathy

